ConductScience.org, home

Paper21898545

CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.

Bizet AA and 5 others. J Cell Biochem, 2012. Cited by 81 papers, by iCite.

Cite this record

ConductScience Library. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function. Papers, record 21898545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21898545

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
PubMed
Journal
J Cell Biochem
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
81
iCite
Relative citation ratio, by iCite
2.17
iCite
Revised in PubMed
2022-03-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bizet AAAlbane A
2Tran-Khanh NNicolas
3Saksena AAnshuman
4Liu KKai
5Buschmann MDMichael D
6Philip AAnie

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
Neoplasm ProteinsMajor topic
Protein Serine-Threonine KinasesMajor topic
Receptors, Transforming Growth Factor betaMajor topic
Smad7 ProteinMajor topic
Transforming Growth Factor betaMajor topic
Ubiquitin-Protein LigasesMajor topic
Animals
COS Cells
Cell Line
Chlorocebus aethiops
GPI-Linked Proteins
HEK293 Cells
Humans
Receptor, Transforming Growth Factor-beta Type I
Receptor, Transforming Growth Factor-beta Type II
Signal Transduction
Ubiquitination

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
FRN13732Canadian Institutes of Health ResearchCanadaPubMed

Source PubMed

Download CSV of grants

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.

PMIDTitleJournalYearIn PapersSource
42328435CD109 Drives Stemness and Chemoresistance in Colorectal Cancer via LRRC8A/AKAP12/PKCα-Mediated STAT3 Activation and WNT Signaling.Int J Biol Sci2026https://conductscience.org/library/papers/42328435PubMed
42064091The role of HECT-type E3 ubiquitin ligases in inflammation.Front Immunol2026https://conductscience.org/library/papers/42064091PubMed
41898693CD109 Deletion Promotes Myofibroblast Differentiation and Smad-Dependent Matrix Accumulation in Skin Fibrosis.Int J Mol Sci2026https://conductscience.org/library/papers/41898693PubMed
41581882Antagonist nanobodies prevent protease inhibition by CD109.J Biol Chem2026https://conductscience.org/library/papers/41581882PubMed
40000880LMO7 drives profibrotic fibroblast polarization and pulmonary fibrosis in mice through TGF-β signalling.Acta Pharmacol Sin2025https://conductscience.org/library/papers/40000880PubMed
39990858CD109, a master regulator of inflammatory responses.Front Immunol2024https://conductscience.org/library/papers/39990858PubMed
39196190Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes.Nat Cardiovasc Res2024https://conductscience.org/library/papers/39196190PubMed
38161417FLOT2 promotes nasopharyngeal carcinoma progression through suppression of TGF-β pathway via facilitating CD109 expression.iScience2024https://conductscience.org/library/papers/38161417PubMed
38049323[Expression characteristics and clinical significance of CD109 in de novo acute myeloid leukemia].Zhonghua Xue Ye Xue Za Zhi2023https://conductscience.org/library/papers/38049323PubMed
36909248Smooth muscle αv integrins regulate vascular fibrosis via CD109 downregulation of TGF-β signalling.Eur Heart J Open2023https://conductscience.org/library/papers/36909248PubMed
36809715IL-4, IL-13 and IFN-γ -induced genes in highly purified human neutrophils.Cytokine2023https://conductscience.org/library/papers/36809715PubMed
36653343Genome-wide screen of otosclerosis in population biobanks: 27 loci and shared associations with skeletal structure.Nat Commun2023https://conductscience.org/library/papers/36653343PubMed
35954339CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.Cancers (Basel)2022https://conductscience.org/library/papers/35954339PubMed
34504806Transforming Growth Factor-β1 Promotes M1 Alveolar Macrophage Polarization in Acute Lung Injury by Up-Regulating DNMT1 to Mediate the microRNA-124/PELI1/IRF5 Axis.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/34504806PubMed
33797167TGF-β superfamily co-receptors in cancer.Dev Dyn2022https://conductscience.org/library/papers/33797167PubMed
32705187Activation of calcium‑sensing receptor‑mediated autophagy in high glucose‑induced cardiac fibrosis in vitro.Mol Med Rep2020https://conductscience.org/library/papers/32705187PubMed
32507856CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.Br J Cancer2020https://conductscience.org/library/papers/32507856PubMed
32483604Network-based Transcriptome-wide Expression Study for Postmenopausal Osteoporosis.J Clin Endocrinol Metab2020https://conductscience.org/library/papers/32483604PubMed
32210029TGF-β Signaling.Biomolecules2020https://conductscience.org/library/papers/32210029PubMed
32133706Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.Cancer Sci2020https://conductscience.org/library/papers/32133706PubMed

See all 54 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD109135228PubTator's text mininghttps://conductscience.org/library/genes/135228NCBI Gene
SMAD74092PubTator's text mininghttps://conductscience.org/library/genes/4092NCBI Gene
SMURF264750PubTator's text mininghttps://conductscience.org/library/genes/64750NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TGFBR17046PubTator's text mininghttps://conductscience.org/library/genes/7046NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21898545

GET https://conductscience.org/api/papers/v1/21898545/cited_by?page=2